Senores Pharmaceuticals Share Price, IPO Listing Live Updates: Senores Pharma IPO debuts Dec 30, oversubscribed 97.86x. Check ...

Senores Pharmaceuticals shares listed at 53% premium on NSE and 52% premium on BSE. Following the bumper debut, the stock ...

The stock ended at ₹562 on the NSE, down ₹38 or 6.33%, and at ₹557.80 on the BSE, down ₹35.90 or 6.05%. During the day, the ...

Shares of Senores Pharmaceuticals are scheduled to be listed on the stock exchanges today on Monday, December 30, following a ...

As compared to the upper end of the IPO price band, Senores Pharmaceuticals' shares closed with 43.7% gains on the NSE, and ...

Senores Pharmaceuticals shares closed 6% below their listing price, although they are still up 43% from the IPO price.

Senores Pharmaceuticals Ltd had a successful IPO, with shares surging over 53% from the issue price of Rs 391. The company's market valuation hit Rs 2,657.29 crore. The proceeds will aid in expanding ...

Senores Pharmaceuticals shares made their Dalal Street debut today after high demand for its initial public offering (IPO). Senores Pharmaceuticals IPO after listing at 53% premium witnessed some ...

Shares of Senores Pharmaceuticals Limited made a healthy debut on the exchange to list at a 53.45% premium. The scrip listed Rs 593.70 per share on BSE, a premium of 51.84% and Rs 600 per share on NSE ...

Senores Pharmaceuticals Ltd witnessed a stellar debut on stock exchanges, with shares surging nearly 43% against the issue ...

The Ahmedabad-based pharmaceutical firm's shares listed at Rs 600 on the National Stock Exchange, a premium of 53.45%.

Senores Pharmaceuticals Ltd shares listed with a premium of over 53% on the BSE and NSE. The IPO received strong investor ...